JP Morgan Chase’s Imunon IMNN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$241 Buy
+134
New +$330 ﹤0.01% 7481
2025
Q1
Sell
-8
Closed -$95 7511
2024
Q4
$95 Buy
+8
New +$92 ﹤0.01% 7013
2023
Q4
Sell
-1
Closed -$11 7683
2023
Q3
$11 Buy
+1
New +$16 ﹤0.01% 7279
2021
Q3
Sell
-6
Closed -$1K 6638
2021
Q2
$1K Buy
+6
New +$1.42K ﹤0.01% 6252
2020
Q4
Hold
0
5765
2020
Q3
Hold
0
5610
2020
Q2
Hold
0
5521
2020
Q1
Sell
-19
Closed -$6K 5488
2019
Q4
$6K Buy
+19
New +$5.77K ﹤0.01% 5450
2019
Q3
Sell
-15
Closed -$5K 5839
2019
Q2
$5K Buy
+15
New +$6.11K ﹤0.01% 5627

Other funds holding IMNN

JP Morgan Chase's IMNN Position: Q2 2026 in Review

JP Morgan Chase opened a new position in Imunon (IMNN) in Q2 2026: 134 shares worth $241. The stake represents ﹤0.01% of the portfolio and ranks #7481 among its holdings. This is a return to the name: JP Morgan Chase previously reported a position in IMNN as recently as Q4 2024.

JP Morgan Chase first reported a position in IMNN in Q2 2019 and has held it in 6 quarters since. The position peaked at $6K in Q4 2019. 23 funds tracked by Wall St. Rank hold IMNN as of Q2 2026.

  • JP Morgan Chase held 134 shares of Imunon worth $241 as of Q2 2026.
  • Imunon was a new JP Morgan Chase position in Q2 2026.
  • Imunon made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #7481 holding.
  • JP Morgan Chase first reported a position in Imunon in Q2 2019 and has held it in 6 quarters since.
  • JP Morgan Chase's Imunon position peaked at $6K in Q4 2019.
  • 23 funds tracked by Wall St. Rank held Imunon as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.